About
Nanoparticles
Areas of Focus
Categories
NanotechSmall Molecule Pharmaceutical
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
450
By Phase
PHASE1: 2PHASE1/PHASE2: 2PHASE2/PHASE3: 1NA: 1
By Status
TERMINATED: 2COMPLETED: 2RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT03589339Lead Sponsor
NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD-1 Therapy
PHASE1Recruiting
145 participants
Started: Jan 16, 2019 · Completed: May 30, 2028
NCT02805894Lead Sponsor
NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma
PHASE1/PHASE2Terminated
5 participants
Started: Nov 15, 2017 · Completed: Mar 19, 2020
NCT02721056Lead Sponsor
NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers
PHASE1/PHASE2Terminated
23 participants
Started: Jan 28, 2016 · Completed: May 6, 2020
NCT02379845Lead Sponsor
NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall
PHASE2/PHASE3Completed
180 participants
Started: Mar 3, 2015 · Completed: Sep 20, 2020
NCT01946867Lead Sponsor
NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or Oropharynx
NAUnknown
75 participants
Started: Jan 3, 2014 · Completed: Feb 28, 2023
Locations (1)
Headquarters
Paris, France
Map
Loading map...